TULA recognized by CIO Applications magazine as “Top 25 Governance, Risk & Compliance (GRC) Technology Providers

TULA recognized by CIO Applications magazine as “Top 25 Governance, Risk & Compliance (GRC) Technology Providers – 2017”

DDi simplified the complete risk management process right from identification to mitigation thereby providing high quality clinical data and reducing clinical operational costs

DDi developed TULA for drug development and clinical programs to manage program performance, vendor oversight, risk control and compliance management in an integrated manner for holistic view in one tool. TULA provides centralized vendor/CRO performance information to organizations and helps them meet regulatory compliance and contractual obligations. TULA has helped several clients and the specific functions include Clinical Operations, Vendor Oversight, Project management and Risk management (including RBM programs)

In an attempt to further build on TULA, DDi provides proprietary Artificial Intelligence and Automation platform – YANA. The platform amalgamates robotic process automation, AI, machine learning, and digitization to identify risk and deliver flexible business operations. In addition to TULA, the company also extends products for clinical development such as mEDC, mIRT (RTSM), ClinMet (Analytics), dattasa (Trial Automation) and safeXchange.

“In drug development and clinical research area, taking appropriate action on a project or a program or a vendor on time is very important as each day lost constitutes to millions according to several industry studies done,” asserts

Mahesh Malneedi, CEO, DDi.

As the Life Sciences industry is highly regulated and several compliance areas are to be followed at each stage, DDi provides solutions with an amalgamation of functional and domain expertise to cater to their…

Full article from the Source…

Back to Top